Jason R. Beam
University of New Mexico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jason R. Beam.
European Journal of Clinical Nutrition | 2015
Ann L. Gibson; Jason R. Beam; Michelle Alencar; Micah Zuhl; Christine M. Mermier
Background/objectives:Traditional tetrapolar bioimpedance spectroscopy (BIS) is performed with the participant supine for 10 min. New vertical analyzers are penetrating clinical, home and fitness markets, but have body water values that differ from supine reference measures. The minimum time standing prior to assessment does not appear in the literature. We investigated the time course of body water shifts in healthy adults undergoing 30-min assessments in supine and vertical positions.Subjects/methods:While seated, participants were prepped for standard tetrapolar electrode placement. Starting position was counterbalanced and body water measurements were taken every 5 min for 30 min in both positions. Participants sat for 2 min prior to switching positions. Of the 64 participants, three were unable to stand for 30 min; their data were excluded. Body size differences were minimized via computation of relative (%) change between time intervals for total body water (TBW), extracellular water (ECW) and intracellular water (ICW).Results:ECW and ICW shifted in opposite directions while participants were supine; as ECW decreased at each time point, ICW increased (P<0.0125). Likewise, when participants stood, ECW increased incrementally (P<0.0125), but the decreases in ICW were not significant. At each time interval, the changes in supine ECW and ICW differed from the standing values (P<0.05). No postural or time differences were found for %change TBW.Conclusions:For TBW, 5 min appears sufficient for fluid stabilization in either position. Supine ECW and ICW stabilization require more than 30 min as does standing ECW.
Nutrition Research | 2015
Michelle Alencar; Jason R. Beam; James J. McCormick; Ailish C. White; Roy M. Salgado; Len Kravitz; Christine M. Mermier; Ann L. Gibson; Carole A. Conn; Deborah Kolkmeyer; Robert T. Ferraro; Chad M. Kerksick
Increased meal frequency (MF) may be associated with improvements in blood markers of health and body composition during weight loss; however, this claim has not been validated. The purpose of the study was to determine if either a 2-meal (2 MF) or 6-meal frequency (6 MF) regimen can improve body composition and blood-based markers of health while consuming a portion-controlled equihypocaloric diet. Eleven (N=11) obese women (52 ± 7 years, 101.7 ± 22.6 kg, 39.1 ± 7.6 kg/m(2)) were randomized into treatment condition (2 MF or 6 MF) for 2 weeks, completed a 2-week washout, and alternated treatment conditions. In pre/post fashion, changes in body composition, glucose, insulin, and lipid components were measured in response to a test meal. Body mass was successfully lost (P ≤ .05) under both feeding regimens (2 MF: -2.8 ± 1.5 vs 6 MF: -1.9 ± 1.5 kg). Altering MF did not impact glucose, insulin, total cholesterol, or low-density lipoprotein cholesterol (P>.05). On average, fat-free mass (FFM) decreased by -3.3% ± 2.6% following the 2 MF condition and, on average, increased by 1.2% ± 1.7% following the 6 MF condition (P ≤ .05). Fasting high-density lipoprotein cholesterol (HDL-C) percentage increased during the 2 MF condition; this was significantly greater than that in the 6 MF condition (1.3% ± 12.2% vs 0.12% ± 10.3%) (P ≤ .05). Overall, reductions in MF (2 MF) were associated with improved HDL-C levels; but the clinical significance is not clear. Alternatively, increased MF (6 MF) did appear to favorably preserve FFM during weight loss. In conclusion, caloric restriction was effective in reducing body mass and attenuating FFM changes in body composition; however, glucose, insulin, and lipid metabolism had no significant differences between MF.
Nutrition | 2015
Jason R. Beam; Ann L. Gibson; Chad M. Kerksick; Carole A. Conn; Ailish C. White; Christine M. Mermier
OBJECTIVE The aim of this study was to investigate the effects of ingesting caffeine and green coffee bean extract on blood glucose and insulin concentrations during a post-exercise oral glucose tolerance test. METHODS Ten male cyclists (age: 26 ± 5 y; height: 179.9 ± 5.4 cm; weight: 77.6 ± 13.3 kg; body mass index: 24 ± 4.3 kg/m(2); VO2 peak: 55.9 ± 8.4 mL·kg·min(-1)) participated in this study. In a randomized order, each participant completed three 30-min bouts of cycling at 60% of peak power output. Immediately after exercise, each participant consumed 75 g of dextrose with either 5 mg/kg body weight of caffeine, 10 mg/kg of green coffee bean extract (5 mg/kg chlorogenic acid), or placebo. Venous blood samples were collected immediately before and after exercise during completion of the oral glucose tolerance test. RESULTS No significant time × treatment effects for blood glucose and insulin were found. Two-h glucose and insulin area under the curve values, respectively, for the caffeine (658 ± 74 mmol/L and 30,005 ± 13,304 pmol/L), green coffee bean extract (637 ± 100 mmol/L and 31,965 ± 23,586 pmol/L), and placebo (661 ± 77 mmol/L and 27,020 ± 12,339 pmol/L) trials were not significantly different (P > 0.05). CONCLUSION Caffeine and green coffee bean extract did not significantly alter postexercise blood glucose and insulin concentrations when compared with a placebo. More human research is needed to determine the impact of these combined nutritional treatments and exercise on changes in blood glucose and insulin.
Journal of Traditional and Complementary Medicine | 2017
Robert A. Vaughan; Ailish C. White; Jason R. Beam; Nicholas P. Gannon; Randi Garcia-Smith; Roy M. Salgado; Marco Bisoffi; Kristina A. Trujillo; Carole A. Conn; Christine M. Mermier
Obesity is an increasingly prevalent and preventable morbidity with multiple behavioral, surgical and pharmacological interventions currently available. Commercial dietary supplements are often advertised to stimulate metabolism and cause rapid weight and/or fat loss, although few well-controlled studies have demonstrated such effects. We describe a commercially available dietary supplement (purportedly containing caffeine, catechins, and other metabolic stimulators) on resting metabolic rate in humans, and on metabolism, mitochondrial content, and related gene expression in vitro. Human males ingested either a placebo or commercially available supplement (RF) in a randomized double-blind placebo-controlled cross-over fashion. Metabolic rate, respiratory exchange ratio, and blood pressure were measured hourly for 3 h post-ingestion. To investigate molecular effects, human rhabdomyosarcoma cells (RD) and mouse myocytes (C2C12) were treated with various doses of RF for various durations. RF enhanced energy expenditure and systolic blood pressure in human males without altering substrate utilization. In myocytes, RF enhanced metabolism, metabolic gene expression, and mitochondrial content suggesting RF may target common energetic pathways which control mitochondrial biogenesis. RF appears to increase metabolism immediately following ingestion, although it is unclear if RF provides benefits beyond those provided by caffeine alone. Additional research is needed to examine safety and efficacy for human weight loss.
Journal of The International Society of Sports Nutrition | 2013
Jason R. Beam; Ann L. Gibson; Chad M. Kerksick; Carole A. Conn; Ailish C. White; Christine M. Mermier
Background Caffeine and chlorogenic acid are two compounds in green coffee beans that alter blood glucose disposal and insulin sensitivity. Caffeine has been shown to decrease glucose disposal and insulin sensitivity when taken 60 minutes prior to an oral glucose tolerance test in humans, whereas chlorogenic acid has been shown to increase glucose disposal and insulin sensitivity in humans. The purpose of this study was to investigate the effect of ingesting caffeine with dextrose or chlorogenic acid with dextrose immediately after an exhaustive bout of cycling on blood glucose and insulin disposal when compared to ingesting dextrose alone. Methods
Journal of Strength and Conditioning Research | 2013
Christine M. Mermier; Micah Zuhl; M. Virginia Wilmerding; Jason R. Beam; Ailish C. White; Roy M. Salgado; J. Marc Beverly
Abstract Mermier, CM, Zuhl, MN, Wilmerding, MV, Beam, JR, White, AC, Salgado, RM, and Beverly, JM. The effects of a harness safety system during maximal treadmill run testing in collegiate middle- and long-distance runners. J Strength Cond Res 27(11): 2934–2938, 2013—This study compared the results of graded maximal treadmill testing with and without a safety harness (SH) spotting system among collegiate middle- and long-distance runners. Thirteen (n = 8 men, n = 5 women) collegiate runners completed 2 randomly selected maximal treadmill tests. One trial used an SH, and one trial used no harness. All tests were separated by at least 48 hours. The subjects began the test at a velocity of 14.5 or 12 km·h−1 with 1% grade for men and women, respectively, and increased 0.80 kilometers/hr per stage. During each trial, metabolic data and running speed values were recorded along with the completion of a safety questionnaire. No significant difference was found for maximal oxygen consumption (60.84 ± 8.89 vs. 60.733 ± 9.38 ml·kg−1·min−1) and velocity at maximal oxygen consumption (5.33 ± 0.62 vs. 5.24 ± 0.57 m·s−1) between the no harness and harness trials, respectively. Test time was found to be significantly longer in the no harness trial (611.06 ± 119.34 vs. 537.38 ± 91.83 seconds, p < 0.05). The results of the safety questionnaire demonstrated that the runners felt significantly more comfortable during the SH trial (p < 0.05).
Central European journal of sport sciences and medicine | 2015
Robert A. Robergs; David S. Kennedy; Ann L. Gibson; Micah Zuhl; Hung-Sheng Hsu; Jason R. Beam; Roy M. Salgado; Ailish C. White; Aditi S. Majumdar; Steve Lawson; Edson Estrada; Gustavo Sierra
Medicine and Science in Sports and Exercise | 2014
Michelle Alencar; Chad M. Kerksick; Jason R. Beam; James J. McCormick; Ailish C. White; Roy M. Salgado; Ann L. Gibson; Christine M. Mermier; Deborah Kolkmeyer; Len Kravitz; Carole A. Conn
Medicine and Science in Sports and Exercise | 2014
David J. Szymanski; Diane C. Boyce; Jason R. Beam; Mike Greenwood
Medicine and Science in Sports and Exercise | 2011
Michelle G. Kulovitz; Jason R. Beam; Micah Zuhl; Christine M. Mermier; Ann L. Gibson